Special Report: The Lab Kickback Risks of “Freebies”
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Lab leaders are at the greatest risk of HIPAA violations when they get complacent about privacy training.
This template helps lab leaders implement a written policy limiting and establishing procedures governing use of PHI for marketing.
This template helps labs create a fact sheet that highlights the key HIPAA-related do’s and don’ts for marketing staff.
Though COVID-19 testing declines continue to negatively affect lab industry profits, the latest figures suggest the worst may be over.
Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.
While overpayments may not be your fault, they expose your lab to the risk of liability under the Affordable Care Act.
What do lab professionals need to do to ensure sufficient documentation for billing clinical laboratory and pathology services?
Performing your own audit to verify compliance and identify problems is one key to achieving a successful FDA audit.
In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.
A recent SCOTUS ruling on a healthcare fraud case could help defend labs against baseless whistleblower cases.